Rockville, Maryland — September 28, 2026 : The global cardiac resynchronization therapy market is valued at USD 7.7 billion in 2026 and is projected to reach USD 16.5 billion by 2036, advancing at a 7.9% CAGR during the forecast period. Fact.MR analysis indicates an absolute opportunity of USD 8.8 billion through 2036 as heart failure treatment programs, hospital electrophysiology...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek